Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    0.3%
    Check dated 2024-07-26T19:08:00.000Z thumbnail image
  2. Check
    yesterday
    Change Detected
    Difference
    0.9%
    Check dated 2024-07-25T18:36:27.000Z thumbnail image
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.0, adding 3 more conditions and noting that the study now includes 18 locations, while the previous version v2.9.7 has been removed.
    Difference
    0.9%
    Check dated 2024-07-23T16:00:17.000Z thumbnail image
  5. Check
    5 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-07-22T14:33:21.000Z thumbnail image
  6. Check
    7 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-07-20T12:17:55.000Z thumbnail image
  7. Check
    8 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-07-19T11:51:13.000Z thumbnail image

Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.